glucuronic acid has been researched along with gliclazide in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Faadhel, MM; Al-Gohary, OM; Al-Kassas, RS | 1 |
| Jin, X; Xiao, L; Zhang, Y; Zhao, Z | 1 |
| Nayak, AK; Pal, D | 2 |
| Awasthi, R; Kulkarni, GT | 2 |
| Mazumder, B; Sharma, VK | 1 |
| Al-Salami, H; Chen-Tan, N; Golocorbin-Kon, S; Lalic-Popovic, M; Martinez, J; Mathavan, S; Mikov, M; Mooranian, A; Mukkur, TK; Negrulj, R; Sciarretta, J; Stojancevic, M | 1 |
| Al-Salami, H; Al-Sallami, HS; Arfuso, F; Chen-Tan, N; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Mukkur, T; Negrulj, R | 1 |
| Al-Salami, H; Al-Sallami, HS; Arfuso, F; Aruso, F; Fakhoury, M; Fang, Z; Golocorbin-Kon, S; Mikov, M; Mooranian, A; Negrulj, R | 1 |
| Al-Salami, H; Arfuso, F; Chen-Tan, N; Mathavan, S | 2 |
| Ahmad, M; Panda, BP | 1 |
13 other study(ies) available for glucuronic acid and gliclazide
| Article | Year |
|---|---|
Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
Topics: Administration, Oral; Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Carriers; Drug Compounding; Gels; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Intestinal Absorption; Male; Microspheres; Particle Size; Rabbits; Solubility; Surface-Active Agents; Tablets; Technology, Pharmaceutical | 2007 |
optimization of extended zero-order release gliclazide tablets using D-optimal mixture design.
Topics: Alginates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Design; Gliclazide; Glucuronic Acid; Hexuronic Acids; Lactose; Tablets | 2008 |
Development, optimization, and anti-diabetic activity of gliclazide-loaded alginate-methyl cellulose mucoadhesive microcapsules.
Topics: Adhesiveness; Administration, Oral; Alginates; Animals; Blood Glucose; Calcium Chloride; Capsules; Chemistry, Pharmaceutical; Cross-Linking Reagents; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Drug Compounding; Female; Gliclazide; Glucuronic Acid; Goats; Hexuronic Acids; Hypoglycemic Agents; Intestinal Mucosa; Male; Methylcellulose; Models, Statistical; Particle Size; Rats; Solubility; Technology, Pharmaceutical; Time Factors | 2011 |
Novel tamarind seed polysaccharide-alginate mucoadhesive microspheres for oral gliclazide delivery: in vitro-in vivo evaluation.
Topics: Administration, Oral; Alginates; Animals; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Gliclazide; Glucuronic Acid; Goats; Hexuronic Acids; Intestinal Mucosa; Male; Microspheres; Plant Extracts; Polysaccharides; Rats; Seeds; Tamarindus; Tissue Adhesives | 2012 |
Development of novel gastroretentive floating particulate drug delivery system of gliclazide.
Topics: Alginates; Animals; Blood Glucose; Calcium Carbonate; Drug Carriers; Gastrointestinal Tract; Gelatin; Gliclazide; Glucose Tolerance Test; Glucuronic Acid; Hexuronic Acids; Hyperglycemia; Hypoglycemic Agents; Hypromellose Derivatives; Male; Methylcellulose; Mice; Mice, Inbred C57BL; Obesity; Particle Size; Pectins | 2012 |
Development of novel gastroretentive drug delivery system of gliclazide: hollow beads.
Topics: Alginates; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Carriers; Drug Delivery Systems; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypoglycemic Agents; Hypromellose Derivatives; Methylcellulose; Microscopy, Electron, Scanning; Particle Size; Pectins; Solubility; Spectroscopy, Fourier Transform Infrared; Time Factors; X-Ray Diffraction | 2014 |
Gastrointestinal transition and anti-diabetic effect of Isabgol husk microparticles containing gliclazide.
Topics: Alginates; Animals; Blood Glucose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diabetes Mellitus, Experimental; Drug Carriers; Gliclazide; Glucose; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Intestine, Small; Microspheres; Particle Size; Psyllium; Rabbits; Solubility; Tablets | 2014 |
An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations.
Topics: Administration, Oral; Alginates; Animals; Capsules; Cholic Acid; Diabetes Mellitus, Type 1; Drug Carriers; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats | 2015 |
Novel artificial cell microencapsulation of a complex gliclazide-deoxycholic bile acid formulation: a characterization study.
Topics: Alginates; Animals; Artificial Cells; Capsules; Chemistry, Pharmaceutical; Deoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Rats; Rheology | 2014 |
Release and swelling studies of an innovative antidiabetic-bile acid microencapsulated formulation, as a novel targeted therapy for diabetes treatment.
Topics: Alginates; Animals; Capsules; Deoxycholic Acid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Delivery Systems; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Rats | 2015 |
The role of the bile acid chenodeoxycholic acid in the targeted oral delivery of the anti-diabetic drug gliclazide, and its applications in type 1 diabetes.
Topics: Administration, Oral; Alginates; Capsules; Chenodeoxycholic Acid; Diabetes Mellitus, Type 1; Drug Compounding; Gliclazide; Glucuronic Acid; Hexuronic Acids; Humans; Hypoglycemic Agents | 2016 |
A comprehensive study of novel microcapsules incorporating gliclazide and a permeation enhancing bile acid: hypoglycemic effect in an animal model of Type-1 diabetes.
Topics: Alginates; Animals; Bile Acids and Salts; Blood Glucose; Capsules; Cell Survival; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Disease Models, Animal; Drug Compounding; Excipients; Gliclazide; Glucuronic Acid; Hexuronic Acids; Hypoglycemic Agents; Particle Size; Solubility; Taurocholic Acid | 2016 |
Alginate immobilization of Escherichia coli MTCC 1652 whole cells for bioconversion of glycyrrhizinic acid and into 18-beta glycyrrhetinic acid.
Topics: Alginates; Biotransformation; Escherichia coli; Glucuronic Acid; Glycyrrhetinic Acid; Glycyrrhiza; Glycyrrhizic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Plant Extracts; Plant Roots; Time Factors | 2013 |